A Breakthrough in Cancer Detection: Canada’s First Multi-Cancer Blood Test
When it comes to cancer, timing changes everything. For decades, early detection has relied on imaging or invasive biopsies that often only catch cancer after symptoms appear. But now, a powerful technology by Clarion Precision Medicine has arrived in Western Canada that can detect up to 59 types of cancer through a single, simple blood draw.
Led by Dr. Branden Reid, this new Cancer Blood Test, also known as a liquid biopsy, is transforming how Canadians approach cancer screening. With exclusive rights to launch this test in Western Canada, Dr. Reid is at the forefront of diagnostic innovation for Canadian patients.
What Is the Cancer Blood Test?
The Cancer Blood Test is a state-of-the-art liquid biopsy that analyzes fragments of DNA released into the bloodstream by cancer cells. These fragments act as a molecular fingerprint, revealing the presence of cancer long before symptoms occur.
It detects up to 59 cancers in a single sample, including those not covered by traditional screenings such as pancreatic, liver, kidney, ovarian, and esophageal cancers. The test is highly accurate, with 88% sensitivity (ability to detect cancer when it is present) and 98% specificity (ability to confirm a true negative result).
This technology is FDA-approved in the United States and is pending Health Canada approval. It is designed for adults aged 40 to 75 who want proactive insight into their health and long-term wellness.
How It Works
- Simple Blood Draw – A small sample is taken and analyzed for trace amounts of DNA shed by cancer cells.
- Advanced DNA Analysis – Proprietary technology searches for unique genomic patterns that indicate cancer.
- Comprehensive Results – Patients receive a detailed report showing whether cancer DNA was detected and, if so, where in the body it may have originated.
- Next Steps for Positives – In the rare event of a positive result (approximately five percent false positive rate), Dr. Reid coordinates a free follow-up CT or MRI within 3 weeks for confirmation.
If imaging confirms the presence of cancer, Dr. Reid ensures urgent referral to the appropriate oncology specialist, fast-tracking the path from detection to treatment.
Why The Cancer Blood Test Matters
Cancer remains Canada’s leading cause of death, with one in two people expected to face a diagnosis in their lifetime. Traditional screening only targets a handful of cancers, such as breast, colon, or cervical, leaving dozens undetected until later stages.
By contrast, this test screens for more than 70 percent of the most lethal cancers in existence. It is 20 times more powerful than a full-body MRI, detecting microscopic DNA fragments invisible to imaging.
For many, this represents peace of mind that no other diagnostic can provide.
Exclusively Available in Western Canada
Dr. Reid holds a license to launch this liquid biopsy technology from Can Scan/Clarion Precision Medicine in Western Canada, making him one of the first physicians in the country to offer this test.
For Western Canadians, this means earlier access to an advanced form of cancer screening that was previously unavailable in the region. In an area where access to specialized diagnostics can sometimes require long wait times or travel to major centers, this test provides a more convenient, local option for proactive health care.
Introducing the Cancer Blood Test to Western Canada also supports the growing demand for preventive medicine across the region. Patients can now pursue annual cancer screening without needing to navigate interprovincial referrals or extended imaging delays, empowering individuals and families to take charge of their health on their own timelines.
This local availability represents an important step toward more equitable access to early detection across Canada and positions Western Canada as an early adopter in preventive oncology.
Who Is It For?
This test is designed for Canadians aged 25 and up, who believe in proactive healthcare:
- Health-Conscious Individuals who prioritize early detection and prevention.
- Occupational groups with exposure to chemicals, such as construction, farming and fire fighters.
- Busy Professionals with access to health spending accounts or private insurance coverage.
- Family Decision-Makers who want reassurance for their loved ones’ long-term health.
- Those with a Family History of Cancer seeking ongoing annual screening for peace of mind.
- Early Adopters of Medical Innovation eager to access tomorrow’s technology today.
At $2740 per test ($2499 per test for corporate or groups of 10 or more people), it represents a premium yet tax-deductible investment in personal health, a price many consider invaluable for the reassurance it provides.
It’s important to note that this test is not suitable for people with a cancer diagnosis within the last 5 years.
The Future of Cancer Screening in Canada
This blood test is not a replacement for routine check-ups with your family physician. It is a complement that fills the gap between traditional screenings and advanced genomic testing.
By empowering Canadians with earlier answers, this test could reshape how we approach cancer care, shifting from reaction to prevention.Dr. Reid’s launch of the Cancer Blood Test marks the beginning of a new era, one where a few drops of blood may one day help save millions of lives.
Because early answers could change everything.
